APA-referens

Van Audenaerde, J. R., Marcq, E., von Scheidt, B., Davey, A. S., Oliver, A. J., De Waele, J., . . . Smits, E. L. (2020). Novel combination immunotherapy for pancreatic cancer: Potent anti‐tumor effects with CD40 agonist and interleukin‐15 treatment. Clin Transl Immunology.

Chicago-stil citat

Van Audenaerde, Jonas RM, et al. "Novel Combination Immunotherapy for Pancreatic Cancer: Potent Anti‐tumor Effects With CD40 Agonist and Interleukin‐15 Treatment." Clin Transl Immunology 2020.

MLA-referens

Van Audenaerde, Jonas RM, et al. "Novel Combination Immunotherapy for Pancreatic Cancer: Potent Anti‐tumor Effects With CD40 Agonist and Interleukin‐15 Treatment." Clin Transl Immunology 2020.

Varning: dessa hänvisningar är inte alltid fullständigt riktiga.